Body
The United States' seafood industry declined precipitously in the months following the emergence of the COVID-19 pandemic, and research shows that targeted federal assistance will be necessary to bring it back.
UC Santa Barbara aquaculture and fisheries professor Halley Froehlich and colleagues suspected as much early on in the pandemic, but for something as large and complex as the seafood industry, the trends were not so obvious. As a result, financial assistance in that direction has been slow.
In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations and transmission mechanisms is crucial. A recent study by the research group of Principal Investigator Andreas Bergthaler at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, in the renowned journal Science Translational Medicine, makes an important contribution to this.
HOUSTON - (Nov. 23, 2020) - Rice University biochemists Michael Stern and James McNew have studied how neurodegeneration kills cells. They've conducted countless experiments over more than a decade, and they've summarized all they've learned in a simple diagram they hope may change how doctors perceive and treat degenerative diseases as varied as Alzheimer's, Parkinson's and muscle atrophy.
PHILADELPHIA (November 23 2020) - Survivors of COVID-19 are a vulnerable population who often have health ramifications from their illness and hospital stay. Upon returning home from acute care, large proportions of survivors experience functional dependencies, pain, dyspnea, and exhaustion. Until now, no data has been available on the outcomes of COVID-19 patients discharged home after hospitalization and their recovery needs.
University of California San Diego School of Medicine researchers found evidence that triclosan -- an antimicrobial found in many soaps and other household items -- worsens fatty liver disease in mice fed a high-fat diet.
The study, published November 23, 2020 in Proceedings of the National Academy of Sciences, also details the molecular mechanisms by which triclosan disrupts metabolism and the gut microbiome, while also stripping away liver cells' natural protections.
VIRTUAL MEETING (CST), November 22, 2020 -- Researchers who study the physics of fluids are learning why certain situations increase the risk that droplets will transmit diseases like COVID-19.
New research from the Prevention Research Center of the Pacific Institute for Research and Evaluation suggests that adverse childhood experiences, often referred to as child maltreatment, are associated with increased odds of substance use among women urban Emergency Department (ED) patients.
President-elect Joe Biden has signaled that fighting the COVID-19 pandemic will be an immediate priority for his administration. He recently announced a coronavirus advisory board of infectious disease researchers and former public health advisers along with an updated strategy that will include increases in testing and contact tracing, as well as transparent communication.
A Basel-led international research team has discovered a connection between the intestinal flora and sites of inflammation in the central nervous system in multiple sclerosis. A specific class of immune cell plays a central role in this newly identified gut-brain axis. The discovery could pave the way for new treatments for MS that target the intestinal flora.
Nursing home residents with medical order forms indicating their treatment preferences were three times more likely to have their current preferences documented in their medical record than residents without the forms, according to a study from Indiana University School of Nursing and IU Center for Aging Research at Regenstrief Institute.
LOS ANGELES (Nov. 20, 2020) -- A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already approved by the U.S. Food and Drug Administration may help prevent coronavirus infections or reduce severity of the disease.
It isn't a death sentence if a COVID-19 patient suffers a cardiac arrest while getting treatment for the virus in the hospital, according to new research that contradicts reports from early on in the pandemic. The new insight from a researcher in the Perelman School of Medicine at the University of Pennsylvania still shows that such events remain deadly, but can be survived at a rate likely near what it was among other hospital inpatients before the pandemic broke out. This analysis was presented during the American Heart Association's annual scientific meeting this month.
New research has discovered a cell type that governs the way bones form and maintain themselves, opening up a potential target for future therapies for bone disorders like osteoporosis. Led by faculty from the Perelman School of Medicine at the University of Pennsylvania, a rodent study showed that bone marrow adipogenic lineage precursors (MALPs) play a distinct role in the way bones remodel themselves. Defects in this process are the key issue at play in osteoporosis, so a therapy using these MALP cells to better regulate bone remodeling could result in better treatments.
Below please find a summary and link(s) of new coronavirus-related content published today in Annals of Internal Medicine. The summary below is not intended to substitute for the full article as a source of information. A collection of coronavirus-related content is free to the public at http://go.annals.org/coronavirus.
Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine
Glaucoma is a chronic condition that affects cells at the back of the eye. It is the leading cause of irreversible blindness worldwide, and is responsible for 1 in 10 cases of serious sight impairment in the UK.
People with glaucoma, or at risk of developing glaucoma, require lifelong monitoring, including regular eye tests to track the progression of the disease. Currently, these examinations require regular hospital visits (e.g., twice yearly, for life) and use expensive, specialist equipment.